Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Neurocrine Biosciences (NBIX) Interest Coverage Ratio (2017 - 2024)

Neurocrine Biosciences filings provide 8 years of Interest Coverage Ratio readings, the most recent being 90.27 for Q1 2024.

  • On a quarterly basis, Interest Coverage Ratio rose 186.95% to 90.27 in Q1 2024 year-over-year; TTM through Dec 2024 was 518.64, a 850.87% increase, with the full-year FY2023 number at 54.54, up 55.53% from a year prior.
  • Interest Coverage Ratio hit 90.27 in Q1 2024 for Neurocrine Biosciences, down from 136.64 in the prior quarter.
  • In the past five years, Interest Coverage Ratio ranged from a high of 136.64 in Q4 2023 to a low of 103.82 in Q1 2023.
  • Median Interest Coverage Ratio over the past 5 years was 9.23 (2020), compared with a mean of 31.65.
  • Biggest five-year swings in Interest Coverage Ratio: soared 1809.09% in 2022 and later crashed 8807.33% in 2023.
  • Neurocrine Biosciences' Interest Coverage Ratio stood at 9.21 in 2020, then tumbled by 159.75% to 5.5 in 2021, then soared by 1809.09% to 94.0 in 2022, then surged by 45.36% to 136.64 in 2023, then plummeted by 33.93% to 90.27 in 2024.
  • The last three reported values for Interest Coverage Ratio were 90.27 (Q1 2024), 136.64 (Q4 2023), and 128.36 (Q3 2023) per Business Quant data.